Bausch Health Companies Forecasts 2024 Revenues Of $9.3B-$9.55B Versus Consensus Of $8.97B, with Adjusted EBITDA Of $3.20B-$3.35B
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies projects its 2024 revenues to be between $9.3B and $9.55B, surpassing the consensus estimate of $8.97B. The company also forecasts its adjusted EBITDA to range from $3.20B to $3.35B.
February 22, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bausch Health Companies anticipates 2024 revenues to exceed analyst expectations, projecting between $9.3B and $9.55B, with adjusted EBITDA of $3.20B-$3.35B.
Bausch Health's projection of higher-than-expected revenues and adjusted EBITDA for 2024 suggests a positive outlook for the company's financial health and operational efficiency. This optimistic forecast is likely to instill confidence in investors, potentially leading to a short-term increase in the stock price. The surpassing of consensus estimates particularly underscores the company's potential for growth and profitability, making this news highly relevant and important for investors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100